Annual Total Long Term Liabilities
$8.81 M
-$3.57 M-28.83%
December 31, 2023
Summary
- As of February 7, 2025, NAMS annual total long term liabilities is $8.81 million, with the most recent change of -$3.57 million (-28.83%) on December 31, 2023.
- During the last 3 years, NAMS annual total long term liabilities has risen by +$8.81 million (+100.00%).
- NAMS annual total long term liabilities is now -28.83% below its all-time high of $12.37 million, reached on December 31, 2022.
Performance
NAMS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$19.07 M
+$5.13 M+36.79%
September 30, 2024
Summary
- As of February 7, 2025, NAMS quarterly total long term liabilities is $19.07 million, with the most recent change of +$5.13 million (+36.79%) on September 30, 2024.
- NAMS quarterly long term liabilities is now at all-time high.
Performance
NAMS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
NAMS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.8% | - |
| 3 y3 years | +100.0% | +54.1% |
| 5 y5 years | +100.0% | +54.1% |
NAMS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -28.8% | +6906.4% | at high | >+9999.0% |
| 5 y | 5-year | -28.8% | -100.0% | at high | >+9999.0% |
| alltime | all time | -28.8% | -100.0% | at high | >+9999.0% |
NewAmsterdam Pharma Company NV Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $19.07 M(+36.8%) |
| Jun 2024 | - | $13.94 M(-17.7%) |
| Mar 2024 | - | $16.93 M(+92.3%) |
| Dec 2023 | $8.81 M | $8.81 M(-22.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $11.41 M(-7.8%) |
| Dec 2022 | $12.37 M(+9744.1%) | $12.37 M(+57.3%) |
| Jun 2022 | - | $7.87 M(+6157.6%) |
| Dec 2021 | $125.70 K(>+9900.0%) | $125.70 K |
| Dec 2020 | $0.00 | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual total long term liabilities?
- What is the all time high annual total long term liabilities for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual total long term liabilities year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for NewAmsterdam Pharma Company NV?
What is NewAmsterdam Pharma Company NV annual total long term liabilities?
The current annual total long term liabilities of NAMS is $8.81 M
What is the all time high annual total long term liabilities for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual total long term liabilities is $12.37 M
What is NewAmsterdam Pharma Company NV annual total long term liabilities year-on-year change?
Over the past year, NAMS annual total long term liabilities has changed by -$3.57 M (-28.83%)
What is NewAmsterdam Pharma Company NV quarterly total long term liabilities?
The current quarterly long term liabilities of NAMS is $19.07 M
What is the all time high quarterly long term liabilities for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly total long term liabilities is $19.07 M